From: Prognostic value of plasma DPP4 activity in ST-elevation myocardial infarction
 | Unadjusted | Model 1 | Model 2 | |||
---|---|---|---|---|---|---|
HR (95% CI) | p value | HR (95% CI) | p value | HR (95% CI) | p | |
MACCE | 1.00 (0.97–1.04) | 0.93 | 1.02 (0.98–1.05) | 0.33 | 1.01 (0.98–1.05) | 0.53 |
CV mortality | 1.01 (0.96–1.06) | 0.71 | 1.03 (0.98–1.08) | 0.26 | 1.01 (0.95–1.06) | 0.83 |
Myocardial infarction | 1.03 (0.95–1.10) | 0.51 | 1.03 (0.96–1.11) | 0.41 | 1.05 (0.96–1.15) | 0.29 |
HF readmission | 1.03 (0.97–1.09) | 0.41 | 1.04 (0.98–1.11) | 0.23 | 1.03 (0.96–1.11) | 0.41 |
Stroke | 0.97 (0.89–1.06) | 0.52 | 0.99 (0.91–1.08) | 0.78 | 0.99 (0.89–1.09) | 0.78 |
Non-CV mortality | 1.05 (0.98–1.12) | 0.18 | 1.08 (1.00–1.16) | 0.04 | 1.06 (0.97–1.16) | 0.18 |
Repeated revascularization | 1.02 (0.99–1.06) | 0.22 | 1.02 (0.99–1.06) | 0.26 | 1.02 (0.98–1.06) | 0.31 |
MACCE (in non-T2DM) | 0.99 (0.95–1.03) | 0.49 | 1.00 (0.96–1.04) | 0.91 | 0.98 (0.94–1.03) | 0.48 |
MACCE (in T2DM) | 1.04 (0.98–1.11) | 0.18 | 1.05 (0.98–1.21) | 0.16 | 1.16 (1.04–1.30) | 0.01 |